Cardio IQ® Lipoprotein Fractionation

Your standard cholesterol test measures the amount of cholesterol riding inside lipoproteins (the particles that carry fats through your blood). But two people with the same LDL cholesterol number can carry very different numbers of particles, and it is the particle count, not the cholesterol cargo, that more directly predicts whether plaque will build up in your arteries. In the Framingham Offspring Study, people whose LDL particle number (LDL-P) was high but whose LDL cholesterol looked normal still faced elevated cardiovascular risk, while those with high LDL cholesterol but low particle counts did not.

This panel uses ion mobility, a technique that physically separates particles by size, to count your lipoprotein particles individually. Instead of a single cholesterol number, you get a profile: how many atherogenic (plaque-forming) particles you have, how small and dense they are, whether triglyceride-rich remnant particles are elevated, and whether your protective large HDL particles are adequate. That combination answers questions a standard lipid panel simply cannot.

What This Panel Reveals

The tests in this panel organize into three clinical themes: particle burden, particle size distribution, and remnant and protective particles. Together they build a picture of your cardiovascular risk from multiple angles.

Atherogenic Particle Burden

LDL-P is the headline number. It counts every LDL particle circulating in your blood, regardless of size. Each LDL particle carries one molecule of apolipoprotein B (apoB) on its surface, and each particle can cross into the artery wall and start plaque formation. A high particle count means more chances for that to happen. In the Women's Health Study, LDL-P predicted incident cardiovascular events even after adjusting for standard lipid measures.

Small LDL-P narrows the focus to the smallest, densest LDL particles. These particles are more easily oxidized (damaged by chemical reactions in the bloodstream), penetrate the arterial lining more readily, and bind less efficiently to the liver's cleanup receptors. In the Atherosclerosis Risk in Communities (ARIC) study, higher concentrations of small dense LDL cholesterol, a measure that closely tracks with particle count, were associated with increased coronary heart disease risk independent of total LDL cholesterol.

Particle Size Distribution

LDL Peak Size tells you the most common diameter of your LDL particles. A peak size below roughly 20.5 nanometers is sometimes called "Pattern B" (small and dense), while a peak above that threshold is "Pattern A" (large and buoyant). Pattern B has been associated with approximately a threefold higher risk of coronary heart disease in the Quebec Cardiovascular Study, though particle number tends to be the stronger predictor.

Medium LDL-P fills in the distribution between large and small LDL. On its own, this fraction has less independent outcome data than small LDL-P, but it helps characterize whether your particles cluster toward the riskier end of the size spectrum or are spread across a range. When medium LDL-P is elevated alongside high small LDL-P, it reinforces a pattern of predominantly small, dense particles.

Remnant and Protective Particles

VLDL Particle Number counts the very low density lipoprotein (VLDL) particles your liver produces to shuttle triglycerides. As these particles shrink, they become intermediate density lipoprotein (IDL) particles, measured here as IDL Particle Number. Both VLDL and IDL are considered "remnant" particles. A Copenhagen General Population Study analysis found that elevated remnant cholesterol (carried primarily in VLDL and IDL) was causally associated with coronary heart disease, independent of LDL cholesterol.

Large HDL-P counts the biggest high density lipoprotein (HDL) particles. Large HDL particles are more effective at reverse cholesterol transport, the process of pulling cholesterol out of artery walls and returning it to the liver. While raising HDL cholesterol with drugs has not reliably reduced events, a higher count of large, functional HDL particles has been associated with lower cardiovascular risk in observational studies like the Multi-Ethnic Study of Atherosclerosis (MESA).

How to Read Your Results Together

The real power of this panel comes from reading the numbers as a set. A single high or low value matters less than the pattern across all seven markers. Here are the most common patterns and what they suggest.

The most clinically significant scenario is the first one: discordance between LDL-P and LDL cholesterol. In the Women's Health Study, those with high LDL-P but low LDL cholesterol had significantly higher rates of cardiovascular events than those with concordant low values. Roughly 20% of the general population shows meaningful discordance, which means their standard cholesterol result is actively misleading.

When Results Can Be Misleading

Acute illness, surgery, or significant weight loss within the past six weeks can temporarily shift particle numbers and sizes. Thyroid dysfunction alters lipoprotein metabolism broadly, so untreated hypothyroidism can inflate LDL-P and shift size distributions toward smaller particles. If your thyroid stimulating hormone (TSH) is abnormal, interpret this panel cautiously until thyroid function is corrected.

Fasting status matters less for particle counts than for triglyceride based measures, but a nonfasting draw can elevate VLDL-P and IDL-P from recent food intake. For the cleanest snapshot, a 10 to 12 hour fast is still recommended. Alcohol consumed within 48 hours can also transiently raise VLDL particle production.

Tracking Over Time

A single draw gives you a snapshot. Serial testing every 6 to 12 months turns that snapshot into a trend. If you start a statin, switch your diet, or begin an exercise program, particle numbers and sizes should respond within 8 to 12 weeks. Tracking LDL-P over time lets you see whether your intervention is actually reducing your plaque-forming particle burden, not just shifting cholesterol concentrations.

Trends in Small LDL-P and LDL Peak Size are especially useful for monitoring metabolic health. As insulin sensitivity improves (through weight loss, carbohydrate reduction, or exercise), small particles typically decrease and peak size shifts upward. That shift often precedes improvements in fasting glucose or HbA1c (a measure of average blood sugar over three months), making this panel an early signal of metabolic progress.

What to Do with Your Results

If your LDL-P is elevated, a conversation with your physician about risk reduction is warranted even if your LDL cholesterol number looks normal. When Small LDL-P dominates the profile, addressing insulin resistance through diet and exercise may be as meaningful as medication.

Elevated VLDL and IDL particle numbers with normal LDL-P should prompt evaluation for triglyceride drivers such as excess refined carbohydrates, alcohol, or poorly controlled blood sugar. Low Large HDL-P is difficult to raise with medication alone, but regular aerobic exercise has been shown to increase large HDL particle counts.

If any pattern looks unfavorable, consider adding apolipoprotein B (apoB) testing for confirmation, lipoprotein(a) to check for inherited risk, and high-sensitivity C-reactive protein (hs-CRP) to assess artery inflammation. Together, those additions give a more complete picture of your cardiovascular risk.